bf/NASDAQ:TGTX_icon.jpeg

COM:TGTHERAPEUTICS

TG Therapeutics Inc

  • Stock

Last Close

34.55

22/11 21:00

Market Cap

3.17B

Beta: -

Volume Today

2.57M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-1.60M
-
1.45M
190.25%
-4.97M
443.95%
-5.22M
5.02%
6.77M
229.67%
8.82M
30.25%
4.85M
45.06%
-11.80M
-
-11.80M
0%
average payables
2.94M
-
4.38M
48.87%
6.67M
52.32%
12.31M
84.54%
20.57M
67.16%
12.94M
37.11%
-228.50K
-
20.78M
9,194.53%
21.01M
1.10%
average receivables
13.58K
-
56.34K
314.76%
135.77K
140.97%
134.94K
0.61%
96.16K
28.74%
101.73K
5.80%
47.50K
53.31%
694.50K
-
694.50K
0%
book value per share
1.58
-
2.35
49.18%
2.23
5.36%
0.73
67.13%
1.08
47.57%
0.32
70.49%
-7.94
2,591.42%
4.50
156.75%
-10.05
323.16%
-11.28
12.22%
1.08
109.58%
capex per share
-0.00
-
-0.00
143.84%
-0.00
69.68%
-0.01
658.40%
-0.00
99.49%
-0.00
3,223.88%
-0.00
24.30%
-0.00
108.80%
-0.00
2.02%
-0.00
96.59%
capex to depreciation
-5.04
-
-4.72
6.29%
-2.73
42.16%
-5.46
99.97%
-0.03
99.51%
-1.02
3,682.07%
-0.46
54.58%
-0.95
105.48%
-0.81
14.96%
-0.03
96.65%
capex to operating cash flow
0.00
-
0.00
0.92%
0.00
78.35%
0.01
491.22%
0.00
99.57%
0.00
2,839.13%
0.00
41.30%
0.00
68.72%
0.00
18.50%
0.00
94.14%
capex to revenue
-0.04
-
-0.12
226.88%
-0.28
127.34%
-2.26
714.80%
-0.01
99.35%
-0.59
3,951.44%
-0.86
45.56%
-2.35
172.52%
-0.06
97.45%
-0.01
91.61%
cash per share
1.79
-
2.31
29.34%
1.69
26.83%
0.92
45.90%
1.36
49.12%
0.91
33.20%
1.59
74.30%
5.25
230.32%
2.38
54.65%
1.19
49.84%
days of inventory on hand
-10.91K
-
days payables outstanding
-211.15
-
57.88K
27,510.11%
days sales outstanding
65.08
-
204.84
214.76%
445.58
117.53%
200.85
54.92%
259.81
29.36%
228.13
12.20%
75.79
-
debt to assets
0.02
-
0.00
79.44%
0.00
41.23%
0.00
32.56%
0.00
4.23%
0.00
38.85%
0.25
31,138.66%
0.07
73.20%
0.21
210.35%
0.43
106.07%
debt to equity
0.02
-
0.00
81.46%
0.00
39.38%
0.00
7.80%
0.00
0.80%
0.00
46.33%
-0.06
2,187.56%
0.08
238.90%
-0.06
173.61%
-0.05
8.57%
dividend yield
earnings yield
-0.21
-
-0.10
49.97%
-0.12
11.83%
-0.34
196.86%
-0.23
32.17%
-0.56
140.87%
-0.18
67.39%
-0.05
73.94%
-0.14
197.02%
-0.13
10.09%
0.00
103.93%
enterprise value
59.37M
-
484.21M
715.57%
489.71M
1.14%
203.08M
58.53%
452.38M
122.76%
267.52M
40.86%
909.06M
239.81%
5.49B
503.72%
2.29B
58.23%
1.58B
30.96%
2.54B
60.27%
enterprise value over ebitda
-3.55
-
-8.83
148.72%
-7.90
10.49%
-2.57
67.45%
-3.81
48.18%
-1.53
59.73%
-5.42
253.45%
-20.10
270.53%
-6.69
66.70%
-8.41
25.67%
122.94
1,561.42%
ev to operating cash flow
-5.49
-
-13.81
151.79%
-10.96
20.66%
-3.30
69.91%
-4.82
46.33%
-2.08
56.99%
-6.85
229.88%
-25.59
273.78%
-7.75
69.69%
-8.98
15.86%
97.29
1,182.94%
ev to sales
389.62
-
3.18K
715.57%
3.21K
1.14%
1.33K
58.53%
2.97K
122.76%
1.76K
40.72%
5.98K
239.81%
36.11K
503.72%
342.71
99.05%
568.28
65.82%
10.86
98.09%
free cash flow per share
-0.43
-
-1.03
141.62%
-0.98
4.82%
-1.26
28.87%
-1.51
19.62%
-1.71
13.17%
-1.50
12.00%
-1.86
23.84%
-2.24
20.18%
-1.30
41.89%
0.18
113.49%
free cash flow yield
-0.11
-
-0.07
40.51%
-0.08
26.37%
-0.27
230.63%
-0.18
32.17%
-0.42
126.33%
-0.14
67.50%
-0.04
73.58%
-0.12
229.04%
-0.11
6.67%
0.01
109.35%
graham net net
-0.17
-
-0.14
14.94%
-0.97
577.66%
-0.14
85.16%
-0.14
3.32%
0.19
235.10%
0.18
3.17%
4.33
2,284.87%
1.22
71.77%
0.20
83.86%
graham number
5.35
-
9.31
74.10%
8.31
10.72%
5.12
38.33%
6.81
32.87%
4.06
40.39%
19.04
369.00%
15.85
16.75%
24.66
55.59%
19.54
20.74%
1.44
92.63%
income quality
0.53
-
0.63
18.91%
0.71
12.95%
0.79
10.86%
0.79
0.55%
0.74
6.10%
0.77
3.37%
0.77
0.06%
0.85
10.61%
0.89
4.59%
2.06
131.63%
intangibles to total assets
0.02
-
0.01
44.54%
0.01
23.55%
0.01
107.14%
0.01
43.75%
0.01
16.41%
0.00
48.71%
0.00
73.94%
0.00
64.80%
0.00
96.12%
0
100%
interest coverage
-24.10
-
-59.87
148.41%
-64.95
8.49%
-31.98
-
-43.23
35.19%
-61.15
41.46%
-18.92
69.06%
1.64
108.64%
interest debt per share
0.07
-
0.04
46.94%
0.03
26.70%
0.00
94.59%
0.00
46.39%
0.00
56.82%
0.52
58,648.69%
0.42
19.70%
0.64
52.92%
0.69
7.52%
0.08
87.67%
inventory turnover
-0.03
-
invested capital
0.02
-
0.00
81.46%
0.00
39.38%
0.00
7.80%
0.00
0.80%
0.00
46.33%
-0.06
2,187.56%
0.08
238.90%
-0.06
173.61%
-0.05
8.57%
market cap
99.11M
-
539.65M
444.47%
544.56M
0.91%
228.04M
58.12%
508.97M
123.19%
309.41M
39.21%
980.89M
217.02%
6.00B
511.65%
2.51B
58.13%
1.60B
36.24%
2.54B
58.34%
net current asset value
-5.81M
-
-1.53M
73.63%
-26.60M
1,636.44%
-3.92M
85.27%
-4.06M
3.75%
19.45M
578.60%
24.75M
27.25%
505.45M
1,942.05%
188.49M
62.71%
33.29M
82.34%
net debt to ebitda
2.38
-
1.01
57.46%
0.89
12.44%
0.32
64.28%
0.48
50.81%
0.24
49.59%
0.43
78.36%
1.87
337.00%
0.64
65.73%
0.10
84.07%
net income per share
-0.81
-
-1.64
103.19%
-1.38
15.77%
-1.60
15.71%
-1.91
19.62%
-2.30
20.43%
-2.03
11.71%
-2.48
22.13%
-2.69
8.49%
-1.51
44.02%
0.09
105.67%
operating cash flow per share
-0.43
-
-1.03
141.62%
-0.98
4.86%
-1.26
28.28%
-1.51
20.28%
-1.71
13.09%
-1.50
12.03%
-1.86
23.76%
-2.24
20.22%
-1.30
41.81%
0.18
113.49%
payables turnover
-1.73
-
0.01
100.36%
receivables turnover
5.61
-
1.78
68.23%
0.82
54.03%
1.82
121.84%
1.40
22.69%
1.60
13.89%
4.82
-
research and ddevelopement to revenue
82.83
-
205.77
148.43%
285.11
38.56%
436.34
53.04%
635.82
45.72%
1.01K
59.13%
976.11
3.53%
999.57
2.40%
29.68
97.03%
40.26
35.65%
0.33
99.19%
return on tangible assets
-0.43
-
-0.65
49.95%
-0.56
13.92%
-1.45
159.47%
-1.23
15.38%
-2.09
70.77%
-1.11
47.22%
-0.46
58.62%
-0.94
105.14%
-1.06
12.66%
0.04
103.64%
revenue per share
0.01
-
0.00
25.40%
0.00
25.36%
0.00
6.92%
0.00
20.99%
0.00
17.96%
0.00
14.60%
0.00
23.38%
0.05
3,738.55%
0.02
59.34%
1.57
7,550.09%
roe
-0.51
-
-0.70
36.21%
-0.62
11.01%
-2.18
252.04%
-1.77
18.94%
-7.22
308.12%
0.26
103.54%
-0.55
315.22%
0.27
148.61%
0.13
50.12%
0.08
40.85%
roic
-0.49
-
-0.69
40.33%
-0.62
10.89%
-2.18
252.07%
-1.77
18.93%
-7.20
307.75%
0.27
103.76%
-0.49
280.55%
0.28
158.24%
0.14
51.33%
0.12
9.88%
sales general and administrative to revenue
50.53
-
160.90
218.44%
130.51
18.89%
82.90
36.48%
144.23
73.99%
136.57
5.31%
137.09
0.38%
801.39
484.57%
22.74
97.16%
29.89
31.40%
shareholders equity per share
1.58
-
2.35
49.18%
2.23
5.36%
0.73
67.13%
1.08
47.57%
0.32
70.49%
-7.94
2,591.42%
4.50
156.75%
-10.05
323.16%
-11.28
12.22%
1.08
109.58%
stock based compensation to revenue
34.15
-
138.50
305.63%
103.01
25.62%
49.28
52.16%
104.64
112.32%
84.78
18.98%
74.57
12.04%
528.22
608.33%
9.16
98.27%
6.89
24.80%
0.06
99.19%
tangible asset value
-799.39K
-
-799.39K
0%
-799.39K
0%
-799.39K
0%
-799.39K
0%
23.24M
3,006.84%
37.82M
62.74%
518.55M
1,271.25%
236.35M
54.42%
57.79M
75.55%
329.59M
470.34%
tangible book value per share
-0.03
-
-0.02
25.40%
-0.02
25.36%
-0.02
6.92%
-0.01
20.99%
0.31
2,490.80%
0.43
38.98%
4.50
950.65%
1.79
60.24%
0.43
76.13%
2.22
420.04%
working capital
35.99M
-
80.09M
122.57%
76.34M
4.68%
33.99M
55.48%
65.36M
92.32%
40.18M
38.53%
64.70M
61.04%
524.19M
710.15%
265.58M
49.33%
115.07M
56.67%

All numbers in (except ratios and percentages)